Pharming Group NV (PHAR)
Pharming Group Market Cap : 1.109B for Feb. 10, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| uniQure NV | 1.539B |
| ProQR Therapeutics NV | 155.91M |
| argenx SE | 51.30B |
| Pharvaris NV | 1.785B |
| NewAmsterdam Pharma Co. NV | 3.956B |
Market Cap Related Metrics
| PE Ratio | 1132.17 |
| PS Ratio | 3.050 |
| Price to Book Value | 4.192 |
| Price to Free Cash Flow | 22.56 |
| Price | 16.19 |
| Earnings Yield | 0.09% |
| Operating PE Ratio | 32.52 |
| Normalized PE Ratio | 134.36 |